secwatch.observer — SEC 8-K summary
======================================

Issuer:     Monte Rosa Therapeutics, Inc. (GLUE)
CIK:        0001826457
Form:       8-K
Filed at:   2026-01-07T23:59:59+00:00
Accession:  0001193125-26-006341
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Monte Rosa Therapeutics terminates ATM stock sale program; no further sales until new prospectus filed
--------------------------------------------------------------------------------

- Effective January 7, 2026, company terminated the ATM prospectus under its shelf registration.
- No further sales of common stock under the Sales Agreement unless new prospectus filed.
- As of termination date, 2,955,082 shares sold for net proceeds of $24.2 million.
- Sales Agreement with Jefferies remains in effect but no sales currently authorized.
- Reason for termination not disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826457/000119312526006341/0001193125-26-006341-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826457/000119312526006341/glue-20260107.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-006341

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer